A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer.
Chen L, Wang P, Di Gioia C, Yuan M, Zhang Z, Miao J, Yan W, Zhao G, Jia Y, Wang N, Zhang Z, Guo H, Marelli G, Dunmall LC, Lemoine NR, Wang Y.
Chen L, et al. Among authors: yuan m.
Front Immunol. 2025 Jan 7;15:1492464. doi: 10.3389/fimmu.2024.1492464. eCollection 2024.
Front Immunol. 2025.
PMID: 39840061
Free PMC article.